XML 113 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Shareholders' Equity
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Shareholders' Equity Shareholders' Equity
Share repurchases
On May 14, 2021, the Board of Directors authorized the repurchase of our ordinary shares up to a maximum dollar limit of $300.0 million (the "2021 Authorization"). The 2021 Authorization expired on July 22, 2024.
On May 17, 2024, the Board of Directors authorized the repurchase of our ordinary shares up to a maximum dollar limit of $500.0 million (the "2024 Authorization"). The 2024 Authorization began on July 23, 2024, following the expiration of the 2021 Authorization, and expires on July 22, 2027.
During the nine months ended September 30, 2025, we repurchased 4.8 million of our ordinary shares for $253.1 million under the 2024 Authorization. During the nine months ended September 30, 2024, we repurchased 1.5 million of our ordinary shares for $100.0 million under the 2024 Authorization and we did not repurchase ordinary shares under the 2021 Authorization.
As of September 30, 2025, we had $146.9 million available for share repurchases under the 2024 Authorization.
Dividends payable
On September 22, 2025, the Board of Directors declared a quarterly cash dividend of $0.20 per ordinary share payable on November 7, 2025, to shareholders of record at the close of business on October 17, 2025. The balance of dividends payable included in Other current liabilities on our Condensed Consolidated Balance Sheets was $32.8 million and $33.9 million at September 30, 2025 and December 31, 2024, respectively.